V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190008671 | 190007769 | 0 | 30.6 | Curative (C) | 2019-06-25 | 2019-10-20 | Irinotecan + Temozolomide | 02 | N | MELPHALAN | 101855085 |
| 190008763 | 190007770 | 1.71 | 45.25 | Adjuvant (A) | 2022-04-04 | 2022-04-12 | PAM x 2 pre-surgery (cycles 1&2) | 02 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101179629 |
| 190008779 | 190007771 | 1.68 | 45 | Neo-adjuvant (N) | 2019-07-15 | 2019-07-31 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 100199904 |
| 190008789 | 190007772 | null | 102.3 | Curative (C) | 2016-05-31 | 2016-06-05 | EW EuroEwing 2012 Arm A VAI | 02 | N | CISPLATIN + RT | 101074975 |
| 190008817 | 190007773 | 1.64 | 49.1 | Palliative (P) | 2020-01-17 | 2020-01-30 | OST Euramos 1 Closed Trial - M | 02 | null | FLUOROURACIL + OXALIPLATIN | 101375934 |
| 190008819 | 190007774 | 1.56 | 77.7 | Palliative (P) | 2021-07-13 | 2022-01-28 | Etoposide oral | 02 | N | CISPLATIN + FLUOROURACIL | 100543326 |
| 190008845 | 190007775 | null | 52.5 | null | 2017-02-03 | 2017-06-11 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | 02 | N | OCTREOTIDE | 100927741 |
| 190008952 | 190007776 | 1.81 | 52.3 | null | 2022-03-19 | 2022-03-19 | Carboplatin AUC 6 - 10 | 1 | null | CARBOPLATIN | 101825577 |
| 190008969 | 190007777 | 1.62 | 91.8 | Curative (C) | null | 2021-09-26 | Cyclophosphamide + Topotecan | 02 | null | NIVOLUMAB | 101317787 |
| 190009022 | 190007778 | 1.77 | 84.1 | Palliative (P) | null | 2022-05-22 | DOXORUBICIN + METHOTREXATE | 02 | N | GEMCITABINE | 100629178 |
| 190009035 | 190007779 | 0 | 57.2 | Palliative (P) | 2015-12-24 | 2016-05-16 | CARBOPLATIN + ETOPOSIDE | Y | N | DOCETAXEL | 100827071 |
| 190009051 | 190007780 | 0 | 40.9 | Curative (C) | 2020-05-20 | 2020-12-01 | DHAP | 02 | N | DOCETAXEL | 100985989 |
| 190009152 | 190007781 | 1.88 | 76 | null | 2021-10-04 | 2021-11-05 | DOXORUBICIN + METHOTREXATE | 02 | null | TRIAL UNSPECIFIED | 100349515 |
| 190009200 | 190007783 | 1.88 | 81.6 | null | 2019-06-07 | 2019-06-22 | Paclitaxel 7 day | 02 | N | CAPECITABINE + OXALIPLATIN | 100160406 |
| 190009215 | 190007784 | 1.88 | 49.8 | null | null | 2019-04-16 | EW EuroEwing 2012 Arm B IE | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100645235 |
| 190009227 | 190007785 | 1.63 | 76.4 | Neo-adjuvant (N) | null | 2020-08-02 | EW EuroEwing 2012 Arm B VDC | null | null | CARBOPLATIN + GEMCITABINE | 101626008 |
| 190009262 | 190007786 | 1.66 | 94.2 | Curative (C) | 2020-02-28 | 2020-02-28 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 100285155 |
| 190009326 | 190007787 | 1.66 | 32.3 | Palliative (P) | 2017-08-20 | 2017-08-26 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100858772 |
| 190009329 | 190007788 | 0 | 20.5 | Neo-adjuvant (N) | 2020-01-07 | 2020-01-22 | Cisplatin + Doxorubicin | 02 | N | FLUOROURACIL + OXALIPLATIN | 100062057 |
| 190009365 | 190007789 | 1.64 | 59.6 | null | 2017-11-23 | 2017-11-24 | Trial Unspecified | null | null | PACLITAXEL | 101285967 |
| 190009370 | 190007790 | 1.64 | 52.3 | null | 2018-09-17 | 2018-09-17 | Dinutuximab Beta | N | N | FLUOROURACIL + IRINOTECAN | 100310839 |
| 190009375 | 190007791 | 0 | 105 | 03 | 2021-12-07 | 2022-03-17 | Cisplatin 7 day | null | null | CISPLATIN | 101571506 |
| 190009391 | 190007792 | 0 | 69.1 | Curative (C) | 2022-02-21 | 2022-03-12 | Doxorubicin + Olaratumab | 02 | null | FLUOROURACIL + IRINOTECAN | 100856565 |
| 190009394 | 190007793 | 1.56 | 82.6 | Curative (C) | 2020-03-02 | 2020-03-30 | Cisplatin + Fluorouracil + RT 5day | 02 | null | AZACITIDINE + VENETOCLAX | 101428911 |
| 190009396 | 190007794 | 0 | 45.8 | Neo-adjuvant (N) | null | 2019-07-31 | OST Euramos 1 Closed Trial - M | 02 | N | CAPE + CARBOPLATIN + CETUXIMAB | 101470043 |
| 190009397 | 190007795 | 1.71 | 57 | null | 2017-01-16 | 2017-01-24 | null | 02 | N | CAPECITABINE + GEMCITABINE | 100097636 |
| 190009449 | 190007796 | 1.82 | 88 | Palliative (P) | 2021-09-02 | 2021-09-02 | Alectinib | 02 | N | CAPECITABINE + CARBOPLATIN | 101848028 |
| 190009469 | 190007797 | 1.75 | 49.9 | null | 2018-05-08 | 2018-11-12 | DHAP | 02 | N | DOCETAXEL | 100346219 |
| 190009475 | 190007798 | 1.6 | 63.4 | null | 2016-09-07 | 2016-10-12 | Irinotecan + Temozolomide | 02 | N | OXALIPLATIN + MDG | 101755166 |
| 190009505 | 190007799 | 1.56 | 21.6 | Neo-adjuvant (N) | 2018-07-06 | 2018-11-30 | MAP + MIFAMURTIDE | 02 | N | GEMCITABINE | 100154257 |
| 190009516 | 190007800 | 1.56 | 111 | Neo-adjuvant (N) | 2021-07-16 | 2021-11-08 | OST Euramos 1 Closed Trial - Ai | N | Y | CYCLOPHOSPHAMIDE + TOPOTECAN | 101835370 |
| 190009548 | 190007801 | 1.6 | 20.3 | null | 2016-10-18 | 2016-12-15 | EW Rel rEECur Irinotecan/Temozolomide | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE + MIFAMURTIDE | 100759437 |
| 190009576 | 190007802 | 1.59 | 115 | Palliative (P) | 2018-07-12 | 2018-07-13 | Docetaxel 100mg/m2 (21 day) | 01 | N | DHAP | 101692741 |
| 190009605 | 190007803 | 0 | 0 | Neo-adjuvant (N) | 2016-11-13 | 2016-12-05 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + DOXORUBICIN | 101617699 |
| 190009610 | 190007804 | 1.55 | null | Palliative (P) | null | 2019-04-30 | OST Euramos 1 Closed Trial - A | 02 | N | OST A | 100120986 |
| 190009619 | 190007805 | 0 | 26.3 | Adjuvant (A) | 2020-06-20 | 2020-07-05 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100675442 |
| 190009636 | 190007806 | 1.75 | null | Neo-adjuvant (N) | 2021-02-12 | 2021-06-27 | CAPECITABINE + TEMOZOLOMIDE | 02 | Y | CYCLOPHOSPHAMIDE + VINCRISTINE | 100342245 |
| 190009668 | 190007807 | 1.8 | 74 | null | 2019-11-25 | 2020-07-13 | Carboplatin + Etoposide iv&po | 02 | N | METHOTREXATE HIGH DOSE | 100473939 |
| 190009699 | 190007808 | 1.56 | 71.3 | Palliative (P) | 2016-08-21 | 2016-09-18 | OST Mifamurtide | null | null | NB HRNBL-1 COJEC IND COURSE B | 101276424 |
| 190009744 | 190007809 | 1.55 | 55.8 | Curative (C) | 2016-06-18 | 2016-08-14 | Carboplatin + Etoposide iv&po | 02 | N | CAV | 100054242 |
| 190009759 | 190007810 | 1.69 | null | Curative (C) | null | 2020-11-27 | Etoposide + Ifosfamide (5 days) | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100644042 |
| 190009768 | 190007811 | 0 | 20.4 | null | null | 2022-02-09 | OST Euramos 1 Closed Trial - IE | 02 | null | CISPLATIN + CYTARABINE | 101135474 |
| 190009770 | 190007812 | 0 | 51.6 | Adjuvant (A) | 2017-11-30 | 2018-01-02 | IMATINIB | null | null | CISPLATIN + CYTARABINE | 101800305 |
| 190009780 | 190007813 | 1.77 | 67.6 | Curative (C) | 2020-01-12 | 2020-03-07 | DOXORUBICIN | 01 | N | DOXORUBICIN | 100020687 |
| 190009824 | 190007816 | 0 | 63.3 | Neo-adjuvant (N) | 2020-01-16 | 2020-01-16 | METHOTREXATE | null | null | METHOTREXATE | 101041721 |
| 190009842 | 190007817 | 1.62 | 53.6 | Curative (C) | 2019-02-28 | 2019-11-17 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100070652 |
| 190009865 | 190007818 | 0 | 59.8 | Palliative (P) | 2020-12-27 | 2021-08-20 | MAP | 02 | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100326896 |
| 190009878 | 190007819 | 1.75 | 87 | Curative (C) | 2019-10-13 | 2019-10-14 | Cisplatin + Etoposide (3 day) | 01 | Y | EURAMOS TRIAL | 100482626 |
| 190009897 | 190007820 | 1.67 | 62.8 | Neo-adjuvant (N) | 2019-04-07 | 2019-12-13 | METHOTREXATE | Y | N | METHOTREXATE | 101513878 |
| 190009905 | 190007821 | 1.72 | 87.4 | Curative (C) | 2018-05-18 | 2019-10-04 | OST Euramos 1 Closed Trial - M | 01 | N | OST M | 100935290 |